GoodRx Holdings, Inc.
GDRX
$2.04
-$0.04-1.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.63% | -3.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.63% | -3.47% | |||
| Cost of Revenue | 30.14% | 0.52% | |||
| Gross Profit | -2.90% | -3.75% | |||
| SG&A Expenses | -20.41% | 2.03% | |||
| Depreciation & Amortization | 8.00% | 8.63% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.01% | 2.92% | |||
| Operating Income | 152.92% | -45.47% | |||
| Income Before Tax | 132.67% | -68.84% | |||
| Income Tax Expenses | 76.03% | -26.03% | |||
| Earnings from Continuing Operations | 384.81% | -91.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 384.81% | -91.29% | |||
| EBIT | 152.92% | -45.47% | |||
| EBITDA | 66.77% | -22.53% | |||
| EPS Basic | 396.88% | -91.11% | |||
| Normalized Basic EPS | 375.45% | -67.93% | |||
| EPS Diluted | 396.88% | -91.11% | |||
| Normalized Diluted EPS | 374.55% | -67.93% | |||
| Average Basic Shares Outstanding | -1.89% | -2.76% | |||
| Average Diluted Shares Outstanding | -2.03% | -2.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||